News

Up to 90% of colorectal cancers can be cured if caught early. Learn about screening options at Fred Hutch to protect your health.
A new clinical trial shows the immunotherapy drug dostarlimab may eliminate the need for surgery and chemotherapy in certain ...
New research has connected toxins produced by E. coli bacteria to the types of colorectal cancer tumors more likely to affect ...
LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, ...
Angela Goodrich, 45, was shocked to be diagnosed with an extremely rare cancer. She shared her story and symptoms with TODAY ...
Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...
Colorectal cancer, long associated with aging, is rising alarmingly in younger adults, especially those born in the 1980s.
Furthermore, those diagnosed with marijuana addiction before they were stricken with colon cancer were 24.4 times more likely ...
LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.
The incidence of pancreatic adenocarcinoma increases across all age groups, whereas colorectal adenocarcinoma increases only among younger age groups.
Novel treatment allowed patients with colorectal cancer to successfully continue taking their cancer treatment with improved quality of life. Acne-like skin rash is a common side effect from ...
Four specific genes serve as a telltale clue to how potentially deadly stomach cancers will develop and progress, a new study ...